Danish biotech firm Bavarian Nordic (BAVA.CO) said on Saturday it plans to ramp up production of its mpox vaccine and work with international health organisations to ensure fair access as the disease has been declared a global public health emergency.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,